Skip to end of metadata
Go to start of metadata

M2P2s #26-40 

M2P2 #26: You learn that your patient doesn’t speak English BUT you have an IRB-approved protocol consent  in the patient’s native language (i.e., the full English version translated). How does the consenting process differ when not using the short-form consenting process? (REVIEWED 12/2017)
M2P2 #27: If consenting is an ongoing process, what does re-consenting mean? (REVISED 12/2017)
M2P2 #28: I made an error when entering information on a paper form, now what?
M2P2 #29: What happened to the cooperative groups?
M2P2 #30: Why does the FDA inspect IRBs and what do they review?
M2P2 #31: What should you do if you notice that there is something missing on the signed informed consent document?
M2P2 #32: What is a Corrective and Preventative Actions (CAPA) Plan?
M2P2 #33: What should I do if I find incorrect or missing information on ( or NIH Clinical Research Studies? - A M2P2 #11 Update
M2P2 #34: My patient has had labs drawn outside of the CC. What do I need to do as the research nurse besides ensuring that we get the results and they are scanned into CRIS?
M2P2 #35: How does the protocol information get onto the CCR Clinical Trials website?
M2P2 #36: Did you know that you can use the ATV system to obtain a Clinical Center (CC) medical record number (MRN)?
M2P2 #37: You learn that one of your patients, who is not an inpatient,  has died. What documentation is required?
M2P2 #38:
What are baseline symptoms and how do I capture them?
M2P2 #39: What does it mean to take a patient/participant off-study?
M2P2 #40: What does it mean to close a study with the IRB? 

Last updated by Grady, Deborah (NIH/NCI) [E] on Dec 18, 2017